Pterostilbene, >=97% (HPLC), solid

Code: p1499-10mg D2-231

Application

Pterostilbene has been used:to investigate its anti-oxidative stress activities and the involvement of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-anti...


read more

Your Price
£256.00 10MG
£307.20 inc. VAT

Application

Pterostilbene has been used:to investigate its anti-oxidative stress activities and the involvement of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-antioxidant response element (ARE) signaling pathwayto determine its effects on transcriptional activation of estrogen receptor-α (ERα) in hormone resistant breast cancer cells)to study its effects on the cytotoxicity of 2-chloroethyl ethyl sulphide (CEES) in human epidermoid carcinoma cells (A-431) through MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide)viability assay

Biochem/physiol Actions

Pterostilbene exhibits antineoplastic properties in some of the malignancies, hence it is considered as an activeanticancer agent. It has the ability to stimulate apoptosis andblock the viability of cell in estrogen-receptorpositive and negative breast cancer cell lines.

Antioxidant, antiproliferative, apoptosis inducer, antihyperglycemic, antidiabetic.

Caution

Air-sensitive

General description

Pterostilbene(trans-3,5-dimethoxy-4-hydroxystilbene), an antioxidant is an analogue of resveratrol. It is present inblueberries, tree woodand some types of grapes.

Packaging

10 mg in glass bottle

assay≥97% (HPLC)
formsolid
InChI keyVLEUZFDZJKSGMX-ONEGZZNKSA-N
InChI1S/C16H16O3/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h3-11,17H,1-2H3/b4-3+
Quality Level100
SMILES stringCOc1cc(OC)cc(C=Cc2ccc(O)cc2)c1
solubilityDMSO: >20 mg/mL, H2O: insoluble
storage conditionprotect from light
storage temp.2-8°C
Cas Number537-42-8
This product has met the following criteria to qualify for the following awards: